Skip to content

Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers

Clinical Study in Healthy Volunteers Evaluating the Performance and Handling of a Urinary Intermittent Catheter With a Newly Developed Swelling Media.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04633291
Enrollment
22
Registered
2020-11-18
Start date
2019-11-05
Completion date
2019-11-28
Last updated
2023-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Site Discomfort, Catheter Site Pain

Brief summary

Investigation of novel swelling media for CE marked intermittent urinary catheters. The study was a randomized, single blinded, cross-over investigation comparing a novel swelling media with a comparator swelling media in 22 adult, healthy, male volunteers.

Detailed description

The CP279 study investigated a novel swelling media for male intermittent urinary catheters. The study was conducted in Denmark and was a single-site, randomized, single blinded, cross-over investigation, testing inferiority of a novel catheter swelling media against a comparator swelling media in 22 adult, healthy, male volunteers. Each participant was randomized to one of two treatment arms, using a randomization sequence of two (i.e., with two different random options for the order in which the participants tested the two swelling media). The study thus contained two test visits, for which the 22 participants tested the two different swelling media, respectively. There was 4-14 days between the test visits and all catheterizations were performed by trained nurses. Due to a visual difference between the products, it was only possible to blind the subjects.

Interventions

DEVICENovel swelling media

Intermittent catheterization through the urethra draining the bladder, performed by a trained nurse.

DEVICEComparator swelling media

Intermittent catheterization through the urethra draining the bladder, performed by a trained nurse.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent given * Minimum 18 years of age and with full legal capacity * Male gender * Willing to refrain from using analgesics up to 24 hours prior to catheterization visits * Negative urine multistix analysis for erythrocytes (microscopic hematuria) * Negative urine multistix analysis for leukocytes and nitrite, or if positive, subsequent negative for bacterial growth in urine culture

Exclusion criteria

* Abnormalities, diseases or surgical procedures performed in the lower urinary tract * Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination) * Participating in other clinical investigations related to urinary tracts system during this investigation (inclusion to termination) or previously participation in this investigation * Known hypersensitivity toward any of the investigational device

Design outcomes

Primary

MeasureTime frameDescription
Overall Discomfort During Nurse CatheterizationImmediately after the procedure/catheterization, up to 5 min.Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Secondary

MeasureTime frameDescription
Withdrawal Discomfort During Nurse CatheterizationImmediately after the procedure/catheterization, up to 5 min.Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.
Urination Discomfort After CatheterizationImmediately after first normal void, up to 5 min.Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.
Catheter Handling During InsertionImmediately after the procedure/catheterization, up to 5 min.Nurse evaluation of how he/she experienced catheter insertion on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy.
Insertion Discomfort During Nurse CatheterizationImmediately after the procedure/catheterization, up to 5 min.Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.
Touch of Catheter CoatingImmediately after the procedure/catheterization, up to 5 min.Nurse evaluation of whether or not it was needed to touch the catheter coating during handling and/or catheterization (yes/no).
Visual Blood During CatheterizationImmediately after the procedure/catheterization, up to 5 min.Nurse evaluation of if he/she experienced visual blood on either the catheter or in the urine during catheterization (yes/no).
Microscopic Blood in Catheter-collected UrineImmediately after the procedure/catheterization, up to 30 min.Dipstick analysis of hematuria (erythrocytes) after catheterization using a semi-quantitative color scale with five categories ranging from negative to 3+: Negative (-). 10 erythrocytes/μL (+/-). 25 erythrocytes/μL (1+). 80 erythrocytes/μL (2+). 200 erythrocytes/μL (3+). At least one fully positive response (i.e., either 1+, 2+ or 3+), the endpoint was considered positive and the outcome was analyzed as a binary response (positive/negative).
Catheter Handling During WithdrawalImmediately after the procedure/catheterization, up to 5 min.Nurse evaluation of how he/she experienced catheter withdrawal on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy.

Countries

Denmark

Participant flow

Recruitment details

During November 2019, 22 users were recruited for the study from one site (Denmark) and encompassed the safety population.

Pre-assignment details

The 22 recruited participant were randomized into the two intervention arms, i.e., using a randomization sequence of two. No participants were excluded and none were discontinued. Thus, 22 participants constituted the safety and the intention to treat (ITT) population.

Participants by arm

ArmCount
Total ITT Population
Each treatment arm consisted of two test visits with 4-14 washout days between each crossover. On each visit, the participants underwent intermittent catheterization through the urethra, draining the bladder, and tested a different intermittent catheter: The comparator catheter (SpeediCath® Standard male with original swelling media) or the test catheter (SpeediCath® Standard male with novel swelling media). All catheterizations were performed by a trained nurse.
22
Total22

Baseline characteristics

CharacteristicTotal ITT Population
Age, Continuous34.7 years
STANDARD_DEVIATION 10.4
Number of participants with presence of hematuria (microscopic)0 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Denmark
22 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 22
other
Total, other adverse events
0 / 220 / 22
serious
Total, serious adverse events
0 / 220 / 22

Outcome results

Primary

Overall Discomfort During Nurse Catheterization

Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureValue (MEAN)Dispersion
Novel Swelling MediaOverall Discomfort During Nurse Catheterization1.75 cmStandard Deviation 1.57
Comparator Swelling MediaOverall Discomfort During Nurse Catheterization1.79 cmStandard Deviation 1.86
Comparison: At a 85% power level, the sample size needed to demonstrate non-inferiority of the novel coating to the original the coating was 18 subjects (participants). This was based on a standard deviation of 1.6 cm, a within subject correlation of 0.5 cm, and an assumption of same VAS distribution for the investigational device as for the comparator. With an expected drop-out rate of 20%, 22 subjects were included.p-value: 0.8895% CI: [-0.5, 0.58]Mixed Models Analysis
Secondary

Catheter Handling During Insertion

Nurse evaluation of how he/she experienced catheter insertion on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy.

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Novel Swelling MediaCatheter Handling During InsertionEasy7 Participants
Novel Swelling MediaCatheter Handling During InsertionDifficult1 Participants
Novel Swelling MediaCatheter Handling During InsertionNeither difficult nor easy4 Participants
Novel Swelling MediaCatheter Handling During InsertionVery difficult2 Participants
Novel Swelling MediaCatheter Handling During InsertionVery easy8 Participants
Comparator Swelling MediaCatheter Handling During InsertionVery difficult1 Participants
Comparator Swelling MediaCatheter Handling During InsertionVery easy6 Participants
Comparator Swelling MediaCatheter Handling During InsertionEasy8 Participants
Comparator Swelling MediaCatheter Handling During InsertionNeither difficult nor easy3 Participants
Comparator Swelling MediaCatheter Handling During InsertionDifficult4 Participants
Comparison: Null hypothesis: No difference between the devices.p-value: 0.38195% CI: [0.47, 6.6]Proportional odds model
Secondary

Catheter Handling During Withdrawal

Nurse evaluation of how he/she experienced catheter withdrawal on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy.

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Novel Swelling MediaCatheter Handling During WithdrawalEasy4 Participants
Novel Swelling MediaCatheter Handling During WithdrawalDifficult0 Participants
Novel Swelling MediaCatheter Handling During WithdrawalNeither difficult nor easy0 Participants
Novel Swelling MediaCatheter Handling During WithdrawalVery difficult1 Participants
Novel Swelling MediaCatheter Handling During WithdrawalVery easy17 Participants
Comparator Swelling MediaCatheter Handling During WithdrawalVery difficult1 Participants
Comparator Swelling MediaCatheter Handling During WithdrawalVery easy13 Participants
Comparator Swelling MediaCatheter Handling During WithdrawalEasy8 Participants
Comparator Swelling MediaCatheter Handling During WithdrawalNeither difficult nor easy0 Participants
Comparator Swelling MediaCatheter Handling During WithdrawalDifficult0 Participants
Comparison: Null hypothesis: No difference between the devices.p-value: 0.54195% CI: [-18.4, 34]Proportional odds model
Secondary

Insertion Discomfort During Nurse Catheterization

Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureValue (MEAN)Dispersion
Novel Swelling MediaInsertion Discomfort During Nurse Catheterization2.17 cmStandard Deviation 1.91
Comparator Swelling MediaInsertion Discomfort During Nurse Catheterization2.03 cmStandard Deviation 1.9
Comparison: At a 85% power level, the sample size needed to demonstrate non-inferiority of the novel coating to the original the coating was 18 subjects (participants). This was based on a standard deviation of 1.6 cm, a within subject correlation of 0.5 cm, and an assumption of same VAS distribution for the investigational device as for the comparator. With an expected drop-out rate of 20%, 22 subjects were included.p-value: 0.6295% CI: [-0.72, 0.44]Mixed Models Analysis
Secondary

Microscopic Blood in Catheter-collected Urine

Dipstick analysis of hematuria (erythrocytes) after catheterization using a semi-quantitative color scale with five categories ranging from negative to 3+: Negative (-). 10 erythrocytes/μL (+/-). 25 erythrocytes/μL (1+). 80 erythrocytes/μL (2+). 200 erythrocytes/μL (3+). At least one fully positive response (i.e., either 1+, 2+ or 3+), the endpoint was considered positive and the outcome was analyzed as a binary response (positive/negative).

Time frame: Immediately after the procedure/catheterization, up to 30 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Novel Swelling MediaMicroscopic Blood in Catheter-collected UrineHematuria positive6 Participants
Novel Swelling MediaMicroscopic Blood in Catheter-collected UrineHematuria negative16 Participants
Comparator Swelling MediaMicroscopic Blood in Catheter-collected UrineHematuria negative16 Participants
Comparator Swelling MediaMicroscopic Blood in Catheter-collected UrineHematuria positive6 Participants
Comparison: Null hypothesis: No difference between the devices.p-value: 195% CI: [0.08, 12.87]Regression, Logistic
Secondary

Touch of Catheter Coating

Nurse evaluation of whether or not it was needed to touch the catheter coating during handling and/or catheterization (yes/no).

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Novel Swelling MediaTouch of Catheter CoatingYes4 Participants
Novel Swelling MediaTouch of Catheter CoatingNo18 Participants
Comparator Swelling MediaTouch of Catheter CoatingYes3 Participants
Comparator Swelling MediaTouch of Catheter CoatingNo19 Participants
Comparison: Null hypothesis: No difference between the devices.p-value: 0.26995% CI: [0.19, 265.95]Regression, Logistic
Secondary

Urination Discomfort After Catheterization

Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Time frame: Immediately after first normal void, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureValue (MEAN)Dispersion
Novel Swelling MediaUrination Discomfort After Catheterization0.52 cmStandard Deviation 0.71
Comparator Swelling MediaUrination Discomfort After Catheterization0.37 cmStandard Deviation 0.59
Comparison: At a 85% power level, the sample size needed to demonstrate non-inferiority of the novel coating to the original the coating was 18 subjects (participants). This was based on a standard deviation of 1.6 cm, a within subject correlation of 0.5 cm, and an assumption of same VAS distribution for the investigational device as for the comparator. With an expected drop-out rate of 20%, 22 subjects were included.p-value: 0.1995% CI: [-0.38, 0.08]Mixed Models Analysis
Secondary

Visual Blood During Catheterization

Nurse evaluation of if he/she experienced visual blood on either the catheter or in the urine during catheterization (yes/no).

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Novel Swelling MediaVisual Blood During CatheterizationYes1 Participants
Novel Swelling MediaVisual Blood During CatheterizationNo21 Participants
Comparator Swelling MediaVisual Blood During CatheterizationYes1 Participants
Comparator Swelling MediaVisual Blood During CatheterizationNo21 Participants
Comparison: Null hypothesis: No difference between the devices.p-value: 195% CI: [0.02, 64.83]Regression, Logistic
Secondary

Withdrawal Discomfort During Nurse Catheterization

Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score.

Time frame: Immediately after the procedure/catheterization, up to 5 min.

Population: The intention to treat population (full analysis set) constituted all randomized subjects with a valid informed consent who was exposed to at least one product, and with valid information on at least one product with respect to the endpoint.

ArmMeasureValue (MEAN)Dispersion
Novel Swelling MediaWithdrawal Discomfort During Nurse Catheterization1.16 cmStandard Deviation 1.09
Comparator Swelling MediaWithdrawal Discomfort During Nurse Catheterization1.27 cmStandard Deviation 1.37
Comparison: At a 85% power level, the sample size needed to demonstrate non-inferiority of the novel coating to the original the coating was 18 subjects (participants). This was based on a standard deviation of 1.6 cm, a within subject correlation of 0.5 cm, and an assumption of same VAS distribution for the investigational device as for the comparator. With an expected drop-out rate of 20%, 22 subjects were included.p-value: 0.6395% CI: [-0.36, 0.57]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026